When the "Methionyl r-Clostridium Botulinum Polypeptide-1 Hexapeptide-40" was developed, a European global cosmetics company official visited BPMed and mentioned : " We have been developing hundreds of raw materials worldwide for decades and all have had a good effect." "However, this was the case when tested on cells and there was no material that significantly transmitted normal skin layers." 

​

   The current cosmetics industry is spending great money on promoting new concept of efficacy and raw materials. However, In the view of BPMed, products that have significant efficacy and technology and the products with sufficient contents are rarely available in the market.

​​

   BPMed, founded by members from the pharmaceutical industry, does not know how to promote and sell cosmetics well, We strive to create innovative cosmetic products that realize real efficacy.